UPSCSTATE-PSC
U.S. FDA qualifies AI tool (AIM-NASH) to analyze liver tissue images, aiding drug development.
Summary
The U.S. FDA has qualified AIM-NASH, a cloud-based AI tool, to analyze liver tissue images. This tool aids in assessing liver diseases, potentially speeding up drug development. This development highlights advancements in AI's application in healthcare and drug research.
Key Points
- The U.S. FDA has qualified AIM-NASH.
- AIM-NASH is a cloud-based AI tool.
- It analyzes liver tissue images.
- The tool helps assess signs of liver diseases.
- It is designed to speed up drug development.
Full Article
The cloud-based system, called AIM-NASH, analyzes images of liver tissue to help doctors assess signs of diseases such as fat buildup, inflammation, and scarring
#upsc#ssc#railway#defence